Berto Acquisition (NASDAQ:TACO – Get Free Report) and Quest Diagnostics (NYSE:DGX – Get Free Report) are both healthcare companies, but which is the superior business? Get Berto Acquisition alerts:Earnings & ValuationThis table compares Berto Acquisition and Quest Diagnostics”s top-line revenue, earnings per share (EPS) and valuation. Analyst RatingsThis is a breakdown of current recommendations and price targets for Berto Acquisition and Quest Diagnostics, as reported by MarketBeat.com. Given Quest Diagnostics’ stronger consensus rating and higher probable upside, analysts clearly believe Quest Diagnostics is more favorable than Berto Acquisition. Net Margins Return on Equity Return on Assets Berto Acquisition N/A N/A N/A Quest Diagnostics 9.18% 16.01% 7.27%Insider and Institutional Ownership88.1% of Quest Diagnostics shares are owned by institutional investors.